Xtx Topco LTD Citius Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $710 Million
- Q1 2024
A detailed history of Xtx Topco LTD transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 77,606 shares of CTXR stock, worth $39,579. This represents 0.01% of its overall portfolio holdings.
Number of Shares
77,606
Previous 12,711
510.54%
Holding current value
$39,579
Previous $9,000
666.67%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
26.8MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.73MShares$4.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$3.57 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$1.5 Million0.0% of portfolio
-
State Street Corp Boston, MA2.21MShares$1.13 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.12MShares$571,3470.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $74.5M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...